Grants Search Results
Need help? Call us at (888) 899-2253
Interested in applying for a St. Baldrick's Foundation grant? Learn more about the grant application process.
Showing 1241-1260 of 2412 results
Zhihong Wang M.D.
Funded: 01-01-2015
through 12-31-2015
Funding Type: Infrastructure Grant
Institution Location:
Detroit, MI
Institution: Wayne State University
affiliated with Children's Hospital of Michigan
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
German Childhood Cancer Foundation
Funded: 01-01-2015
through 12-31-2021
Funding Type: Beneficiary Outside the U.S.
Institution Location:
Bonn, Germany
Institution: Deutsche Kinderkrebsstiftung
Through this partnership with German Childhood Cancer Foundation, proceeds from St. Baldrick's events in Germany fund life-saving research in Germany. St. Baldrick's is proud to partner with German Childhood Cancer Foundation and has been doing so since 2015.
Children's Cancer Foundation Hong Kong
Funded: 01-01-2015
through 12-31-2015
Funding Type: Beneficiary Outside the U.S.
Institution Location:
Hong Kong, Hong Kong
Institution: Children's Cancer Foundation
Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. This grant has funded four projects. The first project is an extension of a previous grant. It aims to accurately measure treatment response by identifying and counting residual leukemia cells in patients following treatment, as a result to avoid under-or over-treatment in the future. The second project explored palliative care needs. Palliative care plays an important role in improving symptom control and psychosocial care for pediatric cancer patients and their families. However, there are no international guidelines specifically made for pediatric palliative care (PPC), with the exception of pain management. A local study is thus needed to explore how PPC can be improved and to identify the essential skills, facilities and services needed in the provision of such care in Hong Kong hospitals and community settings. The third project is a study of a large inter-group randomized trial on whether rituximab (antibody) can add benefit to the current chemotherapy regimen for children and adolescents with high risk B cell non-Hodgkin lymphoma. The fourth project explored cardiac toxicity. Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and mortality associated with its cardiac complications. The field of ‘pediatric cardo-oncology’ has emerged as an essential discipline to provide cardiac specialist care to pediatric cancer patients. In this project multi-modality evaluation on cardiac function is used to monitor the cardiac function of children after cancer therapy.
C. Patrick Reynolds M.D., Ph.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Lubbock, TX
Institution: Texas Tech University Health Sciences Center
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
David G. Poplack M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Houston, TX
Institution: Baylor College of Medicine
affiliated with Vannie E. Cook Jr. Children's Cancer and Hematology Clinic, Texas Children's Hospital
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Dina Hankin Ph.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Oakland, CA
Institution: Children's Hospital and Research Center Oakland
This grant funds the sustainability of a comprehensive long-term follow-up program with the goal to monitor the medical and psychosocial issues that young cancer patients face as they enter into adulthood.
Howard Katzenstein M.D.
Funded: 12-01-2014
through 11-30-2016
Funding Type: Infrastructure Grant
Institution Location:
Nashville, TN
Institution: Vanderbilt University Medical Center
affiliated with Monroe Carell Jr. Children's Hospital at Vanderbilt
This grant funds a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Jean Tersak MD
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Pittsburgh, PA
Institution: Children's Hospital of Pittsburgh
affiliated with University of Pittsburgh
This grant helps provide necessary resources to improve electronic clinical trail management at this institution. This will allow a doctor to easily find available clinical trials for patients.
John Gates M.D.
Funded: 12-01-2014
through 11-30-2016
Funding Type: Infrastructure Grant
Institution Location:
Madera, CA
Institution: Valley Children's Healthcare
This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.
Julio Barredo M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Miami, FL
Institution: Miller School of Medicine of The University of Miami
affiliated with Holtz Children's Hospital
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Jonathan Bernstein M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Las Vegas, NV
Institution: Alliance for Childhood Diseases
affiliated with Children’s Specialty Center of Nevada
This grant helps provide necessary resources for the Long Term Follow-up Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.
Karol Kerr M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Syracuse, NY
Institution: SUNY Upstate Medical University
affiliated with Golisano Children's Hospital, Syracuse
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Mary Lou Schmidt M.D.
Funded: 12-01-2014
through 11-30-2016
Funding Type: Infrastructure Grant
Institution Location:
Chicago, IL
Institution: University of Illinois - Chicago
affiliated with University Of Illinois Hospital & Health Sciences System
Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials. This support of necessary personnel has significantly increased clinical trial participation for patients who otherwise might not have access to them.
Nehal Parikh M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Hartford, CT
Institution: Connecticut Children's Medical Center
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Nobuko Hijiya M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Chicago, IL
Institution: Ann & Robert H. Lurie Children's Hospital
affiliated with Northwestern University
This grant funds a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
The grant is named in honor of the Do It for Dominic Fund. This Hero Fund was created in memory of Dominic Cairo, who died from Non-Hodgkin Lymphoma at the age of 8. His family and friends continue to focus their efforts on raising funds and supporting St. Baldrick’s in the effort find cures for childhood cancers in the hopes that no child ever has to go through what Dominic had to endure.
Thomas McLean M.D.
Funded: 12-01-2014
through 11-30-2016
Funding Type: Infrastructure Grant
Institution Location:
Winston Salem, NC
Institution: Wake Forest University Health Sciences
affiliated with Brenner Children's Hospital
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Amy Fowler M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Austin, TX
Institution: Dell Children's Medical Center of Central Texas
This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Vikramjit Kanwar M.B.B.S, M.R.C.P. (UK)
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Albany, NY
Institution: Albany Medical Center
This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
William H. Meyer M.D.
Funded: 12-01-2014
through 11-30-2015
Funding Type: Infrastructure Grant
Institution Location:
Oklahoma City, OK
Institution: University of Oklahoma Health Sciences Center
affiliated with The Children's Hospital at OU Medical Center
This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.
Gregory Aune M.D., Ph.D.
Funded: 09-01-2014
through 08-31-2019
Funding Type: St. Baldrick's Scholar
Institution Location:
San Antonio, TX
Institution: University of Texas Health Science Center at San Antonio
Based on progress to date, Dr. Aune was awarded new grants in 2017 and 2018 to fund additional years of this Scholar award. Survival from pediatric cancer approaches 80%, but long-term survivors have alarming rates of heart disease as adults. Dr. Aune's lab has developed models to study how pediatric cancer therapies affect the heart. This research aims to determine the potential for new chemotherapy agents to damage the heart. These strategies will lead to a better quality of life for children who survive cancer.